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Vitamin C and vitamin E are known as important cellular antioxidants and are involved in several other
non-antioxidant processes. Generally vitamin C and vitamin E are not synthesized by humans and therefore have to
be applied by nutrition. The absence or deficiency of the vitamins can lead to several dysfunctions and even
diseases (e.g. scurvy). The main interest in this study is that vitamin C and E are known to influence bone formation,
e.g. vitamin C plays the key role in the synthesis of collagen, the major component of the extracellular bone matrix.
In the present study we evaluate the effect of ascorbic acid (vitamin C) and α-tocopherol (vitamin E) on the
proliferation and differentiation of primary bovine osteoblasts in vitro. Starting from standard growth medium we
minimized the foetal calf serum to reduce their stimulatory effect on proliferation.
An improved growth and an increased synthesis of the extracellular matrix proteins collagen type I, osteonectin
and osteocalcin was observed while increasing the ascorbic acid concentration up to 200 μg/ml. Furthermore the
effects of α-tocopherol on cell growth and cell differentiation were examined, whereby neither improved growth
nor increased synthesis of the extracellular matrix proteins collagen type I, osteonectin and osteocalcin were
detected.
Further investigations are necessary to target at better supportive effect of vitamins on bone regeneration, and
healing.
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Diseases like osteoporosis will become more and more a
major public health threat in the near future, e.g. in the
demographic aging trend. The prevention and an effective
treatment against osteoporosis and other bone-associated
diseases is therefore one of the aims in the field of medical
research. Another challenge is the in vitro formation of
bone in the field of tissue engineering.
Proliferation and differentiation of osteoblasts enable
the production of extracellular matrix (ECM) and is
therefore the initial step to generate calcified tissue,
especially bone. During the stages of differentiation,
several proteins are synthesized by the osteoblasts, like
collagen I, the main component of the ECM, and non-
collagenous proteins like alkaline phosphatase, osteonectin* Correspondence: Ulrich.Plate@ukmuenster.de
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reproduction in any medium, provided the orand later in the differentiation progress osteocalcin. Up
to now the scientific world focuses on the elucidation of
the metabolic pathways during biomineralization to get
an idea of how to promote the process of mineralization
in vivo and in vitro. This could in the end lead to new
applications in the coating of implants and prostheses or
to an improvement in the treatment of bone diseases like
osteoporosis. One qualified approach to reach this is to
investigate the influence of different substances on the
proliferation and differentiation of osteoblast like cell cul-
tures in vitro. In this study, we examined two vitamins
that cannot be synthesised by humans: ascorbic acid and
vitamin E in form of α-tocopherol.
In vivo, ascorbate appears to be important as an antioxi-
dant, and it is well-known that ascorbic acid acts as a co-
factor for proline hydroxylase and lysine hydroxylase,
enzymes involved in the process of collagen hydroxylation
[1,2]. Ascorbic acid plays a role in reducing the iron pros-
thetic group of the hydroxylases and seems to be essentialtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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plasma membrane of osteoblasts possesses Na+ dependent
transporter proteins specific for ascorbic acid by which
the intracellular amount of ascorbic acid can be regulated
[3]. In vitro studies show that supplementation of the
medium with ascorbic acid stimulates procollagen hydrox-
ylation, the processing and the fibril assembly [4] as well
as the proliferation and differentiation of several types of
cells [5–8]. The mechanism behind the influence of ascor-
bic acid on the proliferation and differentiation of various
cell types still remains unclear. Besides the promoting
effect of ascorbate, it was also shown that ascorbate
was cytotoxic for cells, inducing for example apoptosis
in HL-60 cells [9]. It was shown that the ECM, espe-
cially collagen I, increases the expression of differenti-
ation markers in different cell types. This could be due
to the presence of mature collagen alone, the amount of
collagen-binding integrins or other pathways that could
also be involved [10].
As second supplement we analysed the influence of
vitamin E (α-tocopherol) on the proliferation and differ-
entiation of our bovine cell culture. α-tocopherol is
known for its antioxidant function through the reduc-
tion of free radicals, influencing the permeability of cell
membranes, stabilizing cells in culture and is regarded
to play a role in wound healing [11,12]. Beyond the anti-
oxidant properties of α-tocopherol other effects due to
specific interactions of this vitamin E with proteins like
enzymes or transcription factors are possible [13]. It is
also discussed that α-tocopherol somehow specifically
enhances the effect of ascorbic acid on cells [14,15].Methods and materials
Most cell culture media, e.g. osteoblasts, are routinely
supplemented with serum as a growth factor require-
ment. Therefore, we first tested our culture system
regarding decreasing concentrations of fetal calf serum
(FCS) (10% to 2%) by stopping proliferation of the cells.
However, our results showed sufficient proliferation of
osteoblasts in the 4% FCS.
For all experiments, medium S (standard) was used
(High growth enhancement medium, GEM, without L-
glutamine; MP Biomedicals, Eschwege, Germany).
Medium S was supplemented with 4% FCS (Biochrom,
Berlin, Germany) as explained above, 10.000 IU/ml peni-
cillin, 10.000 μg/ml streptomycin, 250 μg/ml amphoteri-
cin B and 200 mM L-glutamine (Biochrom KG seromed,
Berlin, Germany).
On the basis of medium S, 8.64 mg/ml β-
glycerophosphate and 25 μg/ml ascorbic acid were
added to achieve medium M. Ascorbic acid (vitamin C;
Sigma-Aldrich, München, Germany) and vitamin E
(Eastman Vitamin E-TPGS-NF Grade Eastman ChemicalWorkington UK) were added in different concentrations,
respectively.Primary osteoblast like cell culture
Primary bovine osteoblast-like cells were used in this
study. These cells were derived from the periosteum of
calf metacarpus according to the instructions of [16].
Tissue explants were cultured for 4 weeks in medium S
(High Growth Enhancement Medium, MP Biomedicals
GmbH, Eschwege, Germany) supplemented with 10%
FCS, 10.000 IU/ml penicillin, 10.000 μg/ml strepto-
mycin, 250 μg/ml amphotericin B, 10 mM ß-
glycerophosphate and 200 mM L-glutamine (Biochrom
KG seromed, Berlin, Germany), at 37 °C and 5% CO2 in
humidified air. The medium was replaced once a week.
When the cells reached confluence, they were harvested
(20 min incubation at 37 °C with 0.4 g collagenase,
98.8 mg HAM's F10 in 10 ml HEPES (2-[4-(2-hydro-
xyethyl)-1-piperazinyl]ethanesulfonic acid), repeated
washing with phosphate-buffered saline (PBS), subse-
quently incubated for 15 min) and centrifuged. Pellets
were resuspended in PBS and the cell number was deter-
mined in a coulter counter (CASYWI Modell TT, Schärfe
System, Reutlingen, Germany).Cell proliferation
10.000/cm2 osteoblasts were seeded on 60 x 15 mm
plastic petri dishes (Nunc, Roskide, Denmark) and cell
proliferation was determined after 5 days, respectively.
Cell morphology evaluation was performed by means of
light microscopy. To determine the cell number digital
photos were taken under standardized conditions and
cells were counted using the software program Image J
(Freeware) with the Plug-in Cell Counter.Cell proliferation with vitamin C
The basis for these investigations was the cell-culture
medium S supplemented with 4% FCS. To obtain
medium M (mineralization) 8,64 g/L β-glycerophosphate
and 0,1 g/L L-ascorbic acid were added to medium S.
Different concentrations of ascorbic acid were added to
the culture medium M to yield medium M with 25 μg/
ml ascorbic acid, M1 with 100 μg/ml ascorbic acid, M2
with 200 μg/ml ascorbic acid, M3 with 300 μg/ml ascor-
bic acid, M4 with 400 μg/ml ascorbic acid, M5 with
500 μg/ml ascorbic acid.Cell proliferation with Vitamin E
In this study and also by others d-alpha-tocopheryl poly-
ethylene glycol 1000 succinate (TPGS) was used [17,18].
Typical properties of Vitamin E TPGS 1000: molecular
weight, approx. 1,513; vitamin E content, mg/g, min.
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cible in all parts, a water-soluble form of vitamin E.
In these experiments medium M with and medium S
without ascorbic acid were used, supplemented with 4%
FCS respectively. Preliminary experiments showed that
supplementation of the media with more than 20 μg/ml
prevented any viability of the osteoblasts (Data not
shown). For this reason vitamin E was used in lower
concentration of 0,16 μg/ml (0,43 μmol/L TPGS). Such
amount of TPGS was shown to be appropriate for cell
culture also by others [17].Figure 1 Influence of different FCS-concentrations (2% up to
10% FCS) on the cell proliferation of osteoblast like cells
cultivated in media M over 5 days.Immunohistochemistry
To test the osteoblastic cell differentiation, collagen I,
osteonectin and osteocalcin were assessed by immuno-
histochemistry. 60.000 osteoblasts/cm2 were seeded in
100 x 20 mm plastic petri dishes (TPP, Trasadingen,
Schweiz). After cultivation for 14 days at 37 °C in an
atmosphere of 5% CO2 in the different media, osteoblast-
like cells were fixed with methanol and primary anti-
bodies were used (diluted 1:100 with Blocking Solution):
anti-collagen I (Biotrend, Cologne, Germany), anti-
osteocalcin (TaKaRa Bio, MoBiTec, Gottingen, Germany),
anti-osteonectin (TaKaRa Bio, MoBiTec, Goettingen,
Germany). For the Dako-En-Vision-System, Dako Cyto-
mation Envision + System Labelled Polymer (HRP) anti
rabbit collagen 1 and HRP anti-mouse osteonectin and
osteocalcin (Dako, Hamburg, Germany) were applied.
Digital images were taken under standardized condi-
tions by fluorescence microscopy (Axioplan 2 Carl
Zeiss, Germany) and processed using the software Axio
Vision 3.1 (Carl Zeiss, Germany).Results
Cell proliferation test with fetal calf serum
For this the medium M was used. Medium M was sup-
plemented with increasing concentrations of fetal calf
serum (FCS) from 2–10% to get information about its
influence on cell vitality and cell proliferation. As shown
in Figure 1 increase in cell proliferation correlated with
the concentration of FCS in the medium (2%-10% FCS),
however occurred even in medium with only 2% FCS.
The highest proliferation of osteoblast like cells was
determined in medium M with 10% FCS, indicated by
the highest cell number detected after 2, 3, 4, and 5 days
in culture (Figure 1). However, proliferation of the cells
was already observed with 2% and 4% FCS (Figure 1 and
Figure 2), respectively. To minimize the promoting effect
of FCS on the proliferation of the osteoblast-like cells,
all following experiments of this study were performed
with medium M containing 4% FCS. On the one hand,
this would guarantee proliferation of the osteoblast-like
cells at all and, on the other hand, lead to apparenteffects of the vitamins C and E on the cell proliferation
in the further experiments.
As seen in Figure 2, the cell number of the osteoblast-
like cells increases rapidly within 5 days in culture with
medium M. Figure 2a shows single cells after one day
with different shapes, widespread large cell bodies lying
on the surface of the petri dishes. In Figure 2b cells after
5 days in culture show a sub-confluent cell monolayer
with long cells lying next to each other.
Cell proliferation with vitamin C
Cell proliferation was assessed for the different concentra-
tions of ascorbic acid. An increase in cell number was
observed for all media with vitamin C addition from
0.0 μg/ml up to 200 μg/ml. (Figure 3). In culture media
with ascorbic acid concentrations of more than 300 μg/ml
nearly no cell proliferation was detected. This was con-
firmed by light microscopy (Figure 4). High amounts of
osteoblasts were visible in the media with ascorbic acid
additions up to 200 μg/ml (Figure 4a-d), respectively,
whereas nearly no cells were seen in media with ascorbic
acid additions from 300 μg/ml and more (Figure 4e-f).
Figure 4a and b show sub-confluent cell layers after
5 days in culture with no and 25 μg/ml ascorbic acid in
the media. In Figure 4c and d the cells have reached
confluence and show characteristic cell morphology with
cuboidal appearance (100 μg/ml and 200 μg/ml), typical
of osteoblast-like cells. Figure 4e, f and g show only a
few cells with rounded shape (300 μg/ml and more).
Immunohistochemical analysis
After 14 days of cell culture, the three typical bone cell
proteins collagen I, osteocalcin and osteonectin were
Figure 2 Cell morphology of osteoblast like cells (M x100) with 4% FCS (a = after 1 day and b= after 5 days in culture, medium M).
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With increasing ascorbic acid concentration of the
medium also the amount of determined collagen I
increased (Table 1 and Figure 5). Such clear correlation
was not observed for osteocalcin and osteonectin. How-
ever as documented in Table 1 and Figure 5, an increase
of osteonectin was detectable in media supplemented
with high concentrations of ascorbic acid (200 μg/ml)
compared to these proteins expressed in media S (with-
out ascorbic acid). These results were confirmed by fur-
ther immuno-histochemical analysis after 20 days (data
not shown). The osteoblasts reached confluence in cul-
ture with 200 μg/ml ascorbic acid in the media
(Figure 5a, c, e). Most of the cells showed a typical cu-
boidal shape. Figure 5b, d and f demonstrate sub-
confluent cell layers (without ascorbic acid).
Cell proliferation with vitamin E (α-tocopherol)
An increase in cell proliferation due to the addition of
α-tocopherol to the media was not observed in any of
the experiments performed within this study. OtherFig 3 Cell proliferation of osteoblast like cells in medium with differe
(without vitamin C).α-tocopherol concentrations in various preliminary tests
also showed no increase in cell proliferation (data not
shown). Figure 6 shows an increase in cell number
over a period of 5 days with and without vitamin E
and C. No effects concerning the composition of the
media and cell proliferation were measurable. In addition,
the results are in good correspondence with the data of
Figure 3 at the same concentration of ascorbic acid
(medium M=25 μg/ml ascorbic acid). Table 2 and
Figure 7 show the results after 14 days of cell culture
with and without vitamin C and E. Collagen I, osteo-
calcin and osteonectin were determined immunohisto-
chemically. Whereas the expression of collagen I was
clearly visible under the used conditions, osteonectin
and osteocalcin were not detectable. The proliferation
of the osteoblasts reached sub-confluent cell layers.
Discussion
Minimizing of fetal calf serum concentration
Fetal calf serum (FCS) is a highly complex composition
of different nutrients and lots of other components, e.g.nt ascorbic acid concentrations and medium S as reference
Figure 4 Osteoblast like cells (M x100) after 5 days in media with various ascorbic acid concentrations (a = 0.0 μg/ml, b = 25 μg/ml,
c = 100 μg/ml, d = 200 μg/ml, e = 300 μg/ml, f = 400 μg/ml, g = 500 μg/ml).
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stimulates cell proliferation, we reduced the concentra-
tion of FCS. The highest proliferation of osteoblast-like
cells was observed in the media with 10% FCS as
described in the literature [19,20]. Also, the typicalTable 1 Protein expression of osteoblast like cells in media S
immunhistochemical results (0 = no signal, 1 =weak signal, 2
Collagen 1
Media S without ascorbic acid 1
Media M with 25 μg/ml ascorbic acid 1
Media M1 with 100 μg/ml ascorbic acid 2
Media M2 with 200 μg/ml ascorbic acid 3appearance of cell morphology in media with 10% FCS
of osteoblasts was shown. At FCS concentrations from
8% to 2% cell proliferation was observed, however the
amount of cells decreased continuously. For our further
experiments we chose 4% FCS. It was also shown thatand media M (roughly estimated from
=middle signal, 3 = strong signal))
osteonectin osteocalcin
0 0
1 0
1 0
2 0
Figure 5 Immunohistochemical analyses (a-f) of collagen I (a, b), osteonectin (c, d), osteocalcin (e, f) of osteoblast like cells (staining
toluidine blue) (g, h) in media with 200 μg/ml ascorbic acid (left column) and without ascorbic acid (right column) after 14 days.
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concentrations does not change.
Effect of ascorbic acid
In the experiments with vitamin C the promoting effect
of ascorbic acid on the cell proliferation and also the dif-
ferentiation of osteoblast-like cells were shown. A simi-
lar effect of vitamin C on osteoblasts was also described
by others [7,21,22]. [21] investigated additions of 5 μg/
ml, 10 μg/ml, 20 μg/ml, 50 μg/ml, and 100 μg/ml vita-
min C to the cell culture medium, respectively. In theirstudies about the effect of vitamin C on human osteo-
blasts they found the highest cell proliferation at a vita-
min C concentration of 50 μg/ml. The results of the
present study showed that the osteoblasts proliferate
with increased concentrations from 0 μg/ml - up to
200 μg /ml vitamin C concentrations; the highest prolif-
eration rate was detected at a level of 200 μg/ml. Other
basic media, a longer cultivation period, as well as differ-
ent types of cells (human osteoblast-like instead of bo-
vine osteoblast-like cells) in the study by [21] can be the
reason for different results.
Figure 6 Cell proliferation of osteoblast like cells in media S and media M (S without and M with 25 μg/ml ascorbic acid) with and
without 0,16 μg/ml vitamin E.
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vitamin C in concentrations of 300 μg/ml and higher
acts “toxic” on bovine osteoblasts. Such cytotoxic
phenomenon of ascorbate was also described by others
[9,23], however the apoptosis-inhibiting effect of ascor-
bate was documented as well [24,25]. One study showed
that not the ascorbate itself but the accompanying
amount of generated H2O2, dependent on the media
used, was responsible for the cytotoxic effect [26]. This
could also explain the observed cell deaths in our study
which can be due to high amounts of H2O2 coming
from the high concentration of ascorbate in the media
used. If there is too much H2O2, the enzyme catalase is
not able to digest all of it into water and oxygen and this
leads to cell death. From this it follows that the adverse
effects of ascorbate seem to be the result of the chosen
in vitro conditions and thus are no good hint to predict
the effect of ascorbate in any situation in vivo. This
process cannot occur in vivo because vitamin C excess
will be excreted. In our in vitro investigations such ex-
cretion was impossible and this could be the reason for
the observed “toxic” effect. Based on our results we can
assume that bone cells grow slower in absence than in
presence of vitamin C. Thus, vitamin C deficiency canTable 2 Difference of protein expression between media S an
signal, 2 =middle signal, 3 = strong signal)
Collag
Media S without Vit. C and without Vit. E 1
Media S without Vit. C and 0,16 μg Vit. E 1
Media M with 25 μg/ml Vit. C and 0,16 μg Vit. E 1inhibit bone formation on both levels, proliferation of
the osteoblasts and differentiation to generate bone
matrix and can be a possible candidate to favor
osteoporosis.
The extracellular matrix proteins collagen type I,
osteocalcin and osteonectin are decisive for bone forma-
tion and bone remodeling. Inhibition of bone formation
and injury of connective tissue caused by a vitamin C
deficiency is accompanied with a decreased collagen bio-
synthesis ([21], 27, [9]). Vitamin C plays an important
role in hydroxylation of lysine and proline in the colla-
gen biosynthesis, for example. In these reactions, which
depend on vitamin C, α-ketoglutarate, O2 and Fe
2 + ions
and the OH group will be attached to lysine and proline.
The stability and strength in the connective tissue are
dependent on these OH groups, because they are re-
sponsible for the binding of collagen and thus for the
hydrogen bonds between the collagen polypeptide
chains. For healing of wounds and bone fractures colla-
gen is essential particularly. The special importance of
vitamin C in collagen biosynthesis was confirmed in the
investigations of several research groups [9,21,27].
[21] found that the highest synthesis of collagen type I,
which is one of the main components of bone matrix,d media M of osteoblast like cells (0 = no signal, 1 =weak
en 1 osteonectin osteocalcin
0 0
0 0
0 0
Figure 7 Immunohistochemical analyses of characteristic extracellular bone proteins: collagen I (a, d, g), osteonectin (b, e, h),
osteocalcin (c, f, i) in media S without vitamin C and E (a-c), with 0,16 μg/ml vitamin E (d-f) and media M with 25 μg/ml vitamin C and
0,16 μg/ml vit. E (g-i) after 14 days.
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media with 100 μg/ml vitamin C, they observed a lower
rate of collagen biosynthesis. Our investigations con-
firmed the stimulation of the production of collagen.
However, in our experiments we used vitamin C concen-
trations up to 200 μg/ml and therefore cannot confirm
the highest collagen formation at 50 μg/ml vitamin C
concentrations; the synthesis of extracellular matrix-
relevant proteins in various concentrations of vitamin C
should be analyzed in future studies. Also both matrix
proteins osteocalcin and osteonectin were detected in
cells with vitamin C. The mineralization process will be
initiated by the formation of osteocalcin [28].
Thus one can assume that bone mineralization is at
least accelerated by vitamin C [27]. It was found that
osteoblasts tend to increase the expression of osteonec-
tin and osteocalcin with an addition of vitamin C. It can
be concluded that the supplementation of 200 μg/ml
vitamin C has a positive effect on the proliferation and
also cell differentiation of osteoblasts in vitro. A suitable
concentration of vitamin C seems to be useful to im-
prove wound healing and bone regeneration.
Effect of α-tocopherol
In the experiments with α-tocopherol, the effect on the
proliferation and differentiation of bovine osteoblastswas examined. Vitamin E (α-tocopherol) is said to have
positive characteristics to bone regeneration [29]. In
experiments in rats, protection against bone loss was
achieved [30]. In previous studies other positive charac-
teristics of vitamin E were shown, e.g. protection against
oxidation and aging by a provision against free radicals,
which reduces the growth of osteoblasts and their differ-
entiation, or by maintenance of bone growth [30–32].
Furthermore, an increase in bone strength without change
in bone density was achieved by vitamin E [29,33]. Also,
a higher proliferation of osteoblast-like cells was expected.
However, in our investigations we could not find an
increasing cell proliferation by α-tocopherol. One reason
could be that the vitamin E concentrations as vitamin
E-TPGS were so high, that vitamin E-TPGS appeared
toxic to the cells. An increase of the bone-characteristic
extracellular matrix proteins collagen type I, osteocalcin
and osteonectin was not shown either. All different media
with vitamin E showed a less immuno-histochemical de-
tection of proteins (data not shown). Again, this result
reinforces the suspicion that the chosen in vitro concen-
trations of vitamin E had toxic effects on the cells com-
parable to vitamin C in vitro. For this reason, we also
used reduced vitamin E-TPGS concentrations. However,
the lowest concentration of vitamin E-TPGS used in
this study in the human physiological area showed no
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bone matrix proteins. Perhaps, further investigations
with much lower concentrations should also follow.
Another reason for the non-occurring higher prolifera-
tion and differentiation under influence of vitamin E
may be the choice of the added vitamin E-TPGS.
Possibly, the use of a D-α-tocopherol-succinate or a
DL-α-tocopherol-acetate would lead to different results.
TPGS, on the other hand, is an extremely hydrophilic
compound that proved to be a useful source of alpha-
tocopherol in certain clinical situations [18]. Vitamin
E-TPGS and its constituent PEG (polyethylene glycol)
were classified as innocuous for humans and animals
in certain concentrations [34]. Soeta et al. showed that
the expression of osteocalcin was decreased by treat-
ment of alpha-tocopherol that was conjugated to bovine
serum albumin [35]. These results indicate that vitamin
E inhibits differentiation of osteoblasts especially from
early stage to osteoid-producing stage.
Possibly, an improved cell growth and a longer lifetime
of cells can be revealed by vitamin E with the awarded
antioxidant activity.
Conclusions
This work demonstrated a positive effect of vitamin C
on the proliferation of primary bovine osteoblasts
in vitro. Vitamin C also increased the synthesis of colla-
gen I. A possible application of the analyzed vitamins
could be the coating of implants. The bio-active vitamins
from the implant surface can be transmitted directly into
the wound. It can be supposed that this increased cell
growth improves wound healing and bone regeneration.
To increase proliferation and collagen formation, the
culture of osteoblast like cells in vitamin-culture media
can be confirmed as quite reasonable.
Our analyses also showed that vitamin E does not
stimulate proliferation of osteoblasts or their production
of collagen type I, osteocalcin and osteonectin.
Further investigations should follow with the aim to
increase the supportive effect of vitamins on biological
processes, such as wound healing, bone regeneration,
and revised healing of bone implants.
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